Original ArticlesSNAP-II and SNAPPE-II: Simplified newborn illness severity and mortality risk scores☆,☆☆
Section snippets
POPULATION SELECTION
We assembled a consortium of 3 independent neonatal research networks (Table I) whose investigators had implemented SNAP as part of their ongoing data collection.We prospectively ensured compatibility of key data elements and study protocols and shared updates throughout. We collected data on all sequential admissions of infants of all birth weights during the designated study periods; we excluded: (1) babies released to the regular nursery in <24 hours; (2) babies admitted to the neonatal
Population
The New England cohort was enriched in very low birth weight cases because 4 of their sites collected data for only babies <1500 g or <32 weeks’ gestational age (Table I). This affected the birth weight distribution, the baseline illness severity as measured by the original SNAP, and the incidence of SGA and low Apgar scores. The “split half” Canadian cohorts appear fully comparable. The Kaiser Permanente cohort tended to have the lowest proportion of smaller, sicker infants. The 20% “outborn”
Discussion
This 30-site study, involving 25,429 newborns, has derived and validated SNAP-II as a measure of newborn illness severity and the SNAPPE-II as a measure of mortality risk. The new scores apply to babies of all birth weights and are simple, rapid, and accurate. It is now feasible to readily incorporate these measures of illness severity and mortality risk into routine databases23 to enhance their utility in outcomes measurement and bench marking.24
The construction of scoring systems uses both
Acknowledgements
We thank Robert Parker for advice on statistical analysis and Lynn Chien for her analyses. John D. Corcoran is currently consultant pediatrician and neonatologist at the Rotunda Hospital in Dublin, Ireland. We also thank all investigators and project staffs of the respective networks.
For the 17 sites in the Canadian NICU Network these include: Wayne Andrews, MD, FRCPC (Charles A. Janeway Child Health Centre, St John’s, NF); Ranjit Baboolal, MD, FRCPC (North York Hospital, North York, ON); Jill
References (30)
The CRIB (Clinical Risk Index for Babies) score: a tool for assessing initial neonatal risk and comparing performance of neonatal intensive care units
Lancet
(1993)- et al.
The Pediatric Risk of Mortality III—Acute Physiology Score (PRISM III-APS): a method of assessing physiologic instability for pediatric intensive care unit patients
J Pediatr
(1997) - et al.
The APACHE III prognostic system. Risk prediction of hospital mortality for critically ill hospitalized adults
Chest
(1991) - et al.
Score for Neonatal Acute Physiology: a physiologic severity index for neonatal intensive care
Pediatrics
(1993) - et al.
Birth weight and illness severity: independent predictors of neonatal mortality
Pediatrics
(1993) - et al.
Score for neonatal acute physiology: validation in three Kaiser Permanente neonatal intensive care units
Pediatrics
(1995) - et al.
Outcome prediction in Greek neonatal intensive care units using a score for neonatal acute physiology (SNAP)
Pediatrics
(1998) - et al.
A comparison of neonatal mortality risk prediction models in very low birth weight infants
Pediatrics
(2000) CRIB (Clinical Risk Index for Babies), mortality, and impairment after neonatal intensive care
Lancet
(1995)- et al.
Use of the CRIB (Clinical Risk Index for Babies) score in prediction of neonatal mortality and morbidity
Arch Dis Child Fetal Neonatal Ed
(1995)
Measuring illness severity in newborn intensive care
J Intensive Care Med
Neonatal risk scoring systems. Can they predict mortality and morbidity?
Clin Perinatol
Risk adjustment for quality improvement
Pediatrics
PRISM III: an updated Pediatric Risk of Mortality score
Crit Care Med
Pediatric risk of mortality (PRISM) score
Crit Care Med
Cited by (931)
Ischemia modified albumin as a marker of hypoxia in preterm infants in the first week after birth
2024, Early Human DevelopmentPalliative care nurse: A quantitative study of caring for neonates at end-of-life stage
2024, Journal of Neonatal NursingAssociation between vancomycin therapeutic drug monitoring and clinical outcomes in treating neonatal sepsis
2023, International Journal of Antimicrobial AgentsThe effects of gestational age on neonatal cholestasis: A retrospective cohort study
2024, Journal of Neonatal-Perinatal Medicine
- ☆
Supported by the Medical Research Council of Canada (MRC grants No. CAAA-40503 and No. 1520); North York General Hospital Foundation; Midland Walwyn Capital Inc; Division of Neonatology, Children’s Hospital of Eastern Ontario; Child Health Program, Health Care Corporation of St John’s; St Joseph’s Health Centre; Lawson Research Institute; University of Western Ontario; Mount Sinai Hospital; Hospital for Sick Children; Women’s College Hospital; Division of Neonatology, Chedoke McMaster Hospital; B.C. Children’s Hospital Foundation; Kaiser Foundation Health Plan, Inc; and The Permanente Medical Group, Inc. Data collection on the New England cohort was performed as part of a grant from the Agency for Health Care Policy and Research (RO1 HS07015).
- ☆☆
Reprint requests: Douglas K. Richardson, MD, MBA, Beth Israel Deaconess Medical Center, Department of Neonatology, 330 Brookline Ave, Boston MA 02215.